https://www.miracle-leukemia.eudailyhttps://www.miracle-leukemia.eu/information/about-us2026-03-11https://www.miracle-leukemia.eu/insights/international-childhood-cancer-day-2026-we-stand-in-support-of-children-battling-leukemia2026-03-11https://www.miracle-leukemia.eu/insights/on-rare-disease-day-we-stand-by-pantients-2026-03-11https://www.miracle-leukemia.eu/insights/miracle-attending-the-european-leukemia-network-annual-meeting2026-03-11https://www.miracle-leukemia.eu/information/consortium2026-02-28https://www.miracle-leukemia.eu/training-education/training--education2026-02-27https://www.miracle-leukemia.eu/insights/bloodcancer-awareness-month2026-02-27https://www.miracle-leukemia.eu/insights/miracle-midterm-meeting-on-20-january-2026-at-amsterdam-umc2026-02-04https://www.miracle-leukemia.eu/insights/miracle-winter-academy-20262026-01-18https://www.miracle-leukemia.eu/insights/best-wishes-for-20262026-01-15https://www.miracle-leukemia.eu/doctoral-candidates/nishika-gupta2025-12-05https://www.miracle-leukemia.eu/insights/miracle-at-eha20252025-10-23https://www.miracle-leukemia.eu/insights/launch-of-the-msca-doctoral-network-miracle-leukemia2025-10-23https://www.miracle-leukemia.eu/insights/miracle-phd-recruitment-campaign-successfully-concluded2025-10-23https://www.miracle-leukemia.eu/insights/miracle-at-eha-research-conference-20252025-10-23https://www.miracle-leukemia.eu/insights/miracle-at-acute-leukemias-xix-isalxix2025-10-23https://www.miracle-leukemia.eu/candidates/10-phd-positions2025-10-23https://www.miracle-leukemia.eu/projects/dc5-the-characterization-of-acute-lymphoblastic-leukemia-mrd-and-relapse-using-single-cell-omics2025-10-23https://www.miracle-leukemia.eu/doctoral-candidates/pierluigi-carulli2025-10-23https://www.miracle-leukemia.eu/doctoral-candidates/matija-kovic2025-10-23https://www.miracle-leukemia.eu/doctoral-candidates/maria-rodrigues-lopes2025-10-23https://www.miracle-leukemia.eu/doctoral-candidates/arif-kozak2025-10-23https://www.miracle-leukemia.eu/doctoral-candidates/alessandro-gagliardi2025-10-23https://www.miracle-leukemia.eu/doctoral-candidates/nurbanu-erolmez2025-10-23https://www.miracle-leukemia.eu/doctoral-candidates/alyssa-rodrigues-alvaro-17612188632025-10-23https://www.miracle-leukemia.eu/doctoral-candidates/mai-huong-pham2025-10-23https://www.miracle-leukemia.eu/doctoral-candidates/thomas-henderson2025-10-23https://www.miracle-leukemia.eu/information/projects2025-09-12https://www.miracle-leukemia.eu/information/doctoral-candidates2025-08-28https://www.miracle-leukemia.eu/projects/dc10-targeting-mrd-and-lscs-in-the-bone-marrow-niche-by-chemokine-modified-dual-targeting-car-t-cells-in-aml2025-08-15https://www.miracle-leukemia.eu/projects/dc9-characterization-of-persisting-leukemic-blasts-in-down-syndrome-patients-to-define-targets-for-immune-therapy-2025-08-15https://www.miracle-leukemia.eu/projects/dc8-therapy-induced-senescence-as-anti-cancer-and-immune-stimulatory-strategy-in-aml-2025-08-15https://www.miracle-leukemia.eu/projects/dc7-dissecting-and-targeting-niche-dependent-vulnerabilities-of-protection-from-therapy-in-aml2025-08-15https://www.miracle-leukemia.eu/projects/dc6-multiomic-and-metabolomic-characterization-of-aml-residual-disease-after-aza-ven-treatment2025-08-15https://www.miracle-leukemia.eu/projects/dc4-characterization-of-aml-mrd-using-single-cell-transcriptomic-and-epigenetic-analysis2025-08-15https://www.miracle-leukemia.eu/projects/dc2-in-depth-analysis-of-phenotypic-acute-leukemia-mrd-dynamics-using-single-sell-data-and-advance-computational-techniques2025-08-15https://www.miracle-leukemia.eu/projects/dc1-optimizing-treatment-decisions-by-using-mrd-data-combined-with-artificial-intelligence2025-08-15https://www.miracle-leukemia.eu/projects/dc3-the-establishment-of-clinical-translational-aml-mrd-on-chip-models2025-08-15https://www.miracle-leukemia.eu/partners/our-partners2025-03-17https://www.miracle-leukemia.eu/objectives/our-objectives2025-03-06https://www.miracle-leukemia.eu/home-projects/our-research-projects2025-03-06https://www.miracle-leukemia.eu/jobs/job-title2025-01-17https://www.miracle-leukemia.eu/information/cookies2025-01-16https://www.miracle-leukemia.eu/information/privacy-policy2025-01-16https://www.miracle-leukemia.eu/keywords/integrated-multi-angle-research-and-training-network-to-eradicate-leukemia-minimal-residual-disease2025-01-16https://www.miracle-leukemia.eu/get-in-touch/miracle-leukemia2025-01-16https://www.miracle-leukemia.eu/get-in-touch/contactmiracle-leukemiaeu2025-01-16https://www.miracle-leukemia.eu/get-in-touch/miracle-leukemiaeu2025-01-16